Literature DB >> 27860134

A Study of the Growth Patterns of Breast Carcinoma Using 3D Reconstruction: A Pilot Study.

Andrea L Merrill1, Julliette Buckley1, Rong Tang1, Elena Brachtel2, Upahvan Rai1, James Michaelson2, Amy Ly2, Michelle C Specht1, Yukako Yagi2, Barbara L Smith1.   

Abstract

Lumpectomy with microscopically clear margins is a safe and effective approach for surgical management of breast carcinoma. Margins are positive for tumor in 18-50% of lumpectomies, as it is not possible to accurately determine the shape or microscopic borders of a tumor preoperatively or intraoperatively. We examined the 3D microanatomy and growth patterns of common breast carcinoma subtypes to provide guidance for lumpectomy surgery. Prospective consent was obtained for the use of excess tissue from patients undergoing lumpectomy or mastectomy for breast carcinoma. Tissue blocks from nine breast carcinomas were serially sectioned. Hematoxylin and eosin-stained slides at 100 μm intervals were scanned using a Nanozoomer (Hamamatsu, Japan) microscopic-resolution scanner. Three-dimensional reconstructions of tumors were created from scanned images using Reconstruct, open-access software. Breast carcinoma subtypes demonstrated characteristic growth patterns within breast tissue, which may have implications for lumpectomy surgery. Invasive ductal carcinomas showed a spherical shape, with a spiculated surface representing tumor cells infiltrating into surrounding parenchyma. Ductal carcinoma in situ appeared to spread along the duct system, creating dilated, tortuous, tumor-filled ducts. The invasive lobular carcinomas examined had a haphazard, linear, infiltrative growth pattern, different from the shape seen in ductal carcinomas. Our preliminary work suggests that invasive ductal and invasive lobular carcinomas appear to have distinct growth patterns in three dimensions and ductal carcinoma in situ appears to grow in a linear fashion along the duct network. The microanatomy studies described have the potential to guide refinements in breast lumpectomy technique.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  3D anatomy; breast carcinoma; lumpectomy; margins; microanatomy

Mesh:

Year:  2016        PMID: 27860134     DOI: 10.1111/tbj.12688

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  5 in total

1.  Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.

Authors:  Barbara L Smith; Michele A Gadd; Conor R Lanahan; Upahvan Rai; Rong Tang; Travis Rice-Stitt; Andrea L Merrill; David B Strasfeld; Jorge M Ferrer; Elena F Brachtel; Michelle C Specht
Journal:  Breast Cancer Res Treat       Date:  2018-06-09       Impact factor: 4.872

2.  A pilot study of micro-CT-based whole tissue imaging (WTI) on endoscopic submucosal dissection (ESD) specimens.

Authors:  Hirotsugu Sakamoto; Makoto Nishimura; Alexei Teplov; Galen Leung; Peter Ntiamoah; Emine Cesmecioglu; Noboru Kawata; Takashi Ohnishi; Ibrahim Kareem; Jinru Shia; Yukako Yagi
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

3.  The shape of breast cancer.

Authors:  Brook K Byrd; Venkataramanan Krishnaswamy; Jiang Gui; Timothy Rooney; Rebecca Zuurbier; Kari Rosenkranz; Keith Paulsen; Richard J Barth
Journal:  Breast Cancer Res Treat       Date:  2020-07-12       Impact factor: 4.872

4.  The Pan-Cytokeratin Staining Intensity and Fractal Computational Analysis of Breast Tumor Malignant Growth Patterns Prognosticate the Occurrence of Distant Metastasis.

Authors:  Nemanja Rajković; Xingyu Li; Konstantinos N Plataniotis; Ksenija Kanjer; Marko Radulovic; Nebojša T Milošević
Journal:  Front Oncol       Date:  2018-08-30       Impact factor: 6.244

Review 5.  Beyond the snapshot: optimizing prognostication and prediction by moving from fixed to functional multidimensional cancer pathology.

Authors:  Cjh Kramer; Mpg Vreeswijk; B Thijssen; T Bosse; J Wesseling
Journal:  J Pathol       Date:  2022-05-23       Impact factor: 9.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.